Table 2. HRMAS MRS metabolite concentrations (mmol/kg) in non-enhancing astrocytoma.
AS2 (mean +/- SD) |
AS3 (mean +/- SD) |
p | |
---|---|---|---|
Alanine | 0.5 +/- 0.5 | 0.7 +/- 0.4 | 0.42 |
Cre+PCre | 3.5 +/- 1.5 | 4.3 +/- 2.2 | 0.28 |
fCho | 0.2 +/- 0.2 | 0.3 +/- 0.2 | 0.31 |
Gln | 1.7 +/- 1.7 | 2.1 +/- 1.6 | 0.61 |
Glu | 2.1 +/- 1.0 | 3.0 +/- 1.9 | 0.22 |
GPC | 1.7 +/- 0.9 | 2.0 +/- 0.9 | 0.39 |
mI | 7.3 +/- 4.0 | 9.5 +/- 5.0 | 0.25 |
NAA | 0.2 +/- 0.3 | 0.2 +/- 0.2 | 0.80 |
PC | 0.3 +/- 0.2 | 0.6 +/- 0.3 | <0.01* |
PC:GPC | 0.3 +/- 0.4 | 0.3 +/- 0.2 | 0.96 |
Tau | 1.3 +/- 0.7 | 1.8 +/- 1.1 | 0.14 |
tCho | 2.3 +/- 0.9 | 2.9 +/- 1.1 | 0.13 |
statistically significant at p ≤ 0.05